Hi all, quick post. Not sure if we can sticky at all or if that...

Hi all, quick post. Not sure if we can sticky at all or if that works here but doesn't matter.
This post should serve purely as an informative comparison for OPERATIONS costs only.
Obviously context is important, don't go by numbers alone. I chose these because they are involved in similar operations and are DEBT FREE.
Also understand NUANCE when reading, do further research to realize some of these companies have higher costs due to funding trials.
Some also have government grants and rebates for R&D to offset their costs.
They grow at different rates, and sales/costs also increase/decrease at different rates.
Need this written down because it is ticking me off whenever this topic is brought up by people who conveniently leave out others.
I could be wrong for financial positions of some companies due to placement etc.

Lets start!
IHL - 50M MC DEBT FREE

Cash Position as of this post - 1.75M, 10.5M in CVL Options, 10M in IHLOB Sep 2020 ITM.

BOT - 200M MC DEBT FREE

Cash Position as of this post - 4.7M, 50M in placement from Cowen & Argonaut & Bell Potter. Don't think dilution has occured yet. Total 54.7M.

AGH - 230M MC DEBT FREE

Cash Position as of this post - 14.9M, Placement due August 9th 2019 for 30M. Dilution has not occurred to MC yet. Total 44.9M.

ZLD - 61M MC DEBT FREE

Cash Position as of this post - 3.08M.

MXC - 63M MC DEBT FREE

Cash Position as of this post - 2.3M.

BOD - 48M MC DEBT FREE

Cash Position as of this post - 2.8M. Investment from H2 Wellness for 7M on 22 July. Total 9.8M.

Hope this helps. Never use this alone as a guide, do not misconstrue this post as advice.
Also try not to bash any company listed here. The rising tide lifts ALL ships!